Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance

Author(s):
Berns, K.; Sonnenblick, A.; Gennissen, A.; Brohee, S.; Hijmans, E.M.; Evers, B.; Fumagalli, D.; Desmedt, C.; Loibl, S.; Denkert, C.; Neven, P.; Guo, W.; Zhang, F.; Knijnenburg, T.A.; Bosse, T.; Heijden, M.S. van der; Hindriksen, S.; Nijkamp, W.; Wessels, L.F.A.; Joensuu, H.; Mills, G.B.; Beijersbergen, R.L.; Sotiriou, C.; Bernards, R.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-11-01
Language
English
Is part of
Clinical Cancer Research (2016), Vol. 22, no. 21, p. 5238-5248
hdl
1887/112946
doi
10.1158/1078-0432.CCR-15-2996